BioClinica looks to service more CROs with new RTP office

By Zachary Brennan contact

- Last updated on GMT

BioClinica looks to service more CROs with new RTP office

Related tags: North carolina

Service provider BioClinica will open a Research Triangle Park (RTP) office in North Carolina in response to a rapidly expanding customer base of study sponsors and CROs (contract research organizations) with which it has strategic partnerships.   

BioClinica said it serves a dozen customers within the region, including a growing number of CROs that use its technology and support services to provide enhanced offerings to sponsors.

This strengthens our commitment in RTP as well as the greater Southern US​," BioClinica CEO John Hubbard said. "The new quarters put us within arm's reach of our customers​.”

BioClinica's entire eClinical product line will be available from this location. A large classroom at the office will also provide for hands-on training for product users and strategic partners.

Several home-based employees will work in the new space, initially designed to accommodate 40 employees and with room for expansion, the company said. BioClinica now has more than 1,300 employees working in a network of offices in the US, Europe and Asia.

Related news

Show more

Related products

show more

Overcoming Challenges of Clinical Data Review

Overcoming Challenges of Clinical Data Review

PerkinElmer | 10-Jun-2021 | Technical / White Paper

Clinical data review is intrinsic to clinical development, assuring patient safety, determining drug efficacy, and assessing data quality. It involves...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Transforming Clinical Development

Transforming Clinical Development

PerkinElmer | 01-Jun-2021 | Technical / White Paper

The estimated cost of bringing a drug to market in the U.S. according to JAMA is $1 billion.1 The extreme cost of clinical trials urge biopharmaceutical,...

Related suppliers

Follow us


View more